Method and use of visible light regulating angiogenesis based on diode light modulation technology

Through 590nm LEDs yellow light regulates angiogenesis of human microvascular endothelial cells and inhibits the secretion of VEGFA and SCF, it solves the treatment problem of combined capillary dilated melasma, achieves effective relief and long-term maintenance of melasma, and provides a A gentle, safe and economical treatment.

CN115521900BActive Publication Date: 2024-11-05AFFILIATED HUSN HOSPITAL OF FUDAN UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202210869955.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-07-23
Publication Date
2024-11-05
Estimated Expiration
2042-07-23

AI Technical Summary

Technical Problem

Melasma is a complex pigment-proliferative skin disease. The existing treatment methods are unsatisfactory and its pathogenesis is unclear. Especially, there is a lack of effective gentle treatments for capillary dilated melasma.

Method used

The 590nm LEDs yellow light was used for light regulation, which regulates the angiogenesis of human microvascular endothelial cells, inhibits the secretion of VEGFA and SCF, affects angiosynthesis and melanin production, thereby interfering with the pathological process of melasma.

Benefits of technology

Under safe doses, the yellow light of LEDs significantly inhibits the migration and tube formation ability of human microvascular endothelial cells, reduces the secretion of vascular endothelial growth factors and stem cell factors, effectively alleviates facial erythema and pigmentation in patients with melasma, and clinical trials have shown that it The efficacy is not inferior to traditional laser treatment, and it is safe, cheap and technically difficult.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115521900B_ABST
    Figure CN115521900B_ABST
Patent Text Reader

Abstract

The present invention belongs to the technical field of biotechnology and phototherapy application, and relates to a method and application of regulating blood vessels with visible light based on LED light modulation technology, using a wavelength of 590±10nm and a power density of 35mW / cm 2 And the energy density is 20J / cm 2 or 40J / cm 2 The results showed that it did not affect cell activity and apoptosis within the safe dose range, and could effectively inhibit cell migration, cell tube formation, cell synthesis and secretion of VEGFA and SCF, and other biological functions, and this effect was achieved by inhibiting the phosphorylation of the AKT / PI3K / mTOR pathway. This method can explain the mechanism of action of 590nm LEDs yellow light from the perspective of blood vessels, which will help provide important basis for the treatment and medical cosmetology of pigmented hyperplastic skin diseases such as chloasma combined with capillary dilation.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of biotechnology and phototherapy application technology, and relates to a method and use of visible light regulating blood vessels based on diode (LED) light modulation technology. The method can be used to establish a treatment platform for pigmented hyperplastic skin diseases such as chloasma combined with capillary dilation. Background Art

[0002] Clinical practice shows that melasma is a common acquired hyperpigmented skin disease that occurs in young and middle-aged women and people with dark skin. Clinically, it often manifests as symmetrical and irregular yellow-brown pigmentation spots on the face. At present, the pathogenesis of melasma is still unclear. Studies have found that factors such as vascular changes and abnormal blood rheology are also involved in the pathogenesis of melasma. Histological studies have shown that melasma is not just a disease limited to melanocytes. Compared with the surrounding healthy tissue, the proliferation of solar elastic collagen, increased dermal mast cells, increased angiogenesis and destruction of the basement membrane can be observed in the lesions of melasma. Therefore, scholars in this field currently believe that melasma is a photoaging disease. In clinical practice, melasma can be divided into simple pigment type and pigment combined with vascular type according to the involvement of blood vessels. Due to its complex etiology, the exact pathogenesis is still unclear, and the current treatment effect is not satisfactory, there is an urgent need to seek a mild and effective treatment method suitable for long-term maintenance and control of melasma.

[0003] In clinical practice, photobiomodulation or low-level laser therapy (LLLT) refers to the use of photons to change biological activity through non-thermal damage. Light-emitting diodes (LEDs), known as the fourth generation of lighting sources and green light sources, have the characteristics of energy saving, environmental protection, long life, and small size. Over the years, LEDs have been used in dermatology fields such as combating skin photoaging, herpes virus infection, promoting wound healing, anti-scar formation, and treating psoriasis and atopic dermatitis. Among them, 590nm LEDs yellow light has the advantages of simple operation, mild safety, home use, few adverse reactions, and relatively low cost. Weiss et al. used 590nm LEDs yellow light for phototherapy for more than 900 patients. The study found that among patients who used LEDs light alone, 90% of the subjects felt that their skin texture improved and their skin texture decreased, and 60% of the patients showed overall improvement in facial texture, erythema, and pigmentation. It has certain prospects in the treatment of melasma. In the early stage of this research group, 20J / cm 2Medical 585nm LEDs yellow light therapy device was used to treat chloasma patients. After the treatment, the average chloasma area and severity index score decreased. Clinically, it can be observed that the facial erythema of the patients was significantly relieved, and the facial red area was significantly reduced after VISIA image analysis. Industry researchers are concerned that in addition to the direct effect on melanocytes and the indirect regulation of melanin synthesis through keratinocytes, does LEDs yellow light have a certain effect on the phenotype and function of human vascular endothelial cells?

[0004] Based on the foundation and current status of the prior art, the inventors of this application intend to provide a method and use of visible light regulating blood vessels based on diode (LEDs) light modulation technology. This method can be used to prepare products for treating pigmented hyperplastic skin diseases such as chloasma combined with capillary dilation.

[0005] This invention will study the effect of LED light modulation on the biological characteristics of human microvascular endothelial cells, explore a new method to regulate angiogenesis of human microvascular endothelial cells, and further attempt to explain the mechanism of 590nm LED yellow light intervention affecting chloasma from the perspective of blood vessels. This invention will provide important help in the treatment and medical cosmetology of pigmented hyperplastic skin diseases such as chloasma combined with capillary dilation. Summary of the invention

[0006] The purpose of the present invention is to provide a method and use of visible light regulating blood vessels based on diode (LEDs) light modulation technology based on the foundation and current status of the existing technology. This method can be used to prepare products or platforms for treating pigmented hyperplastic skin diseases such as chloasma combined with capillary dilation.

[0007] The present invention provides a method for regulating angiogenesis of human microvascular endothelial cells based on LEDs illumination technology. The present invention can explain the mechanism of LEDs 590nm yellow light intervention in chloasma from the perspective of blood vessels, and further help provide important basis for the treatment and medical cosmetology of pigmented hyperplastic skin diseases such as chloasma combined with capillary dilation.

[0008] The present invention conducted a cell model experiment, and the results confirmed that 590nm LEDs did not affect the cell activity of human microvascular endothelial cells in vitro at a safe irradiation dose, and could inhibit cell migration and tube formation; and could inhibit the synthesis and secretion of vascular endothelial growth factor-A (VEGFA) and stem cell factor (SCF) by human microvascular endothelial cells in vitro. VEGFA is closely related to blood vessel synthesis, and 590nm LEDs may inhibit the migration of human microvascular endothelial cells in vitro and the secretion of VEGFA by inhibiting the AKT / PI3K / mTOR pathway, while SCF is closely related to melanogenesis.

[0009] Furthermore, the method of the present invention helps to establish a technical platform for treating chloasma based on LEDs light modulation technology, and explains the specific mechanism from the perspective of blood vessels, which helps to establish an intervention treatment platform for pigment hyperplastic skin diseases such as chloasma combined with capillary dilation.

[0010] Specifically, the present invention conducted a cell model experiment, and the specific screening steps were as follows:

[0011] 1) Human microvascular endothelial cell culture: 2×10 5 / ml density was inoculated in T25, cultured at 37℃, the medium was changed regularly, and the cells were passaged every 2-3 days according to their growth status;

[0012] 2) 590nm LEDs: The wavelength of the light source used is 590±10nm, continuous emission mode, and the power measured after passing through the culture plate cover is 35mW / cm 2 According to the dosage requirements of subsequent experiments, the irradiation time is selected according to the formula W = P × t; the light modulation effect is non-thermal, and there is no obvious change in the bottom temperature of the culture plate after the irradiation. After the irradiation, the complete culture medium is replaced and the subsequent experiments are carried out at the corresponding time point;

[0013] 3) Screening of safe doses of LEDs: Use optical microscopy to observe cell morphology, use CCK8 method and AnnexinV-FITC / PI flow cytometry double staining method to determine cell activity and apoptosis, detect the effects of 590nm LEDs on cell activity and apoptosis, and screen out the energy range of 590nm LEDs yellow light that has no effect on the activity and apoptosis of isolated human microvascular endothelial cells: 0-40J / cm 2 ;

[0014] 4) According to the screening results of step 3), the human microvascular endothelial cells are illuminated with different safe doses of 590nm LEDs yellow light, the cell migration ability is detected by scratch test, the cell tube formation ability is detected by tube formation experiment, the expression of VEGFA and SCF genes and protein levels is detected by RT-PCR and ELISA, and the AKT / PI3K / mTOR pathway is detected by Western Blot.

[0015] The method of regulating angiogenesis of human microvascular endothelial cells based on LEDs light modulation technology of the present invention has been shown by experimental results to have no effect on human microvascular endothelial cells under a safe dose of 590nm LEDs yellow light, and is safe and effective, and can provide a reference for in vitro research on the mechanism of action of LEDs light modulation.

[0016] Furthermore, based on the method of regulating angiogenesis by the light modulation effect of LEDs of the present invention, and the research showing that angiogenesis is closely related to the occurrence and development of chloasma, the present invention further conducted clinical trial experiments, and the results showed that compared with the traditional photoelectric treatment of chloasma: low-energy 1064nm Q-switched neodymium-doped yttrium aluminum garnet laser phototherapy group (energy 700-1000mJ / P, gradually increasing, frequency 2Hz, 3 rounds of scanning, 5 treatments, once every 4 weeks, for 16 consecutive weeks), the LEDs 590nm yellow light trial group (continuous irradiation mode, irradiation light intensity 10mW / cm 2 , irradiation distance: 2cm±1cm, trial irradiation time 5 minutes, once a day, for 16 consecutive weeks, total irradiation dose 21J / (cm 2 * Week)) is not inferior to 1064nm Q-switched Nd:YAG laser in terms of efficacy, safety and self-evaluation of subjects, and its effect in alleviating erythema is more obvious, indicating that LEDs590nm yellow light can be used as a mild and effective intervention measure for chloasma, especially for patients with chloasma combined with vascular dilation. The clinical trial results of the present invention show that LEDs light has the advantages of mildness and safety, low price, low technical difficulty, and can be used at home.

[0017] The method of regulating blood vessels with visible light based on diode (LED) light modulation technology of the present invention can be used to prepare products for treating pigmented hyperplastic skin diseases such as chloasma combined with telangiectasia, for example, to establish a platform for the treatment and long-term maintenance of pigmented hyperplastic skin diseases such as chloasma combined with telangiectasia. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 : CCK8 method and Annexin V-FITC / PI flow cytometry double staining method were used to detect the effects of LEDs on cell activity and apoptosis.

[0019] Figure 2:The scratch assay was used to detect the migration ability of human microvascular endothelial cells after LED illumination.

[0020] Figure 3 :The tube formation experiment detects the tube formation ability of human microvascular endothelial cells after LEDs illumination.

[0021] Figure 4 :RT-PCR and ELISA experiments were used to detect the synthesis and secretion of VEGFA and SCF in human microvascular endothelial cells after LEDs illumination.

[0022] Figure 5 :Western Blot was used to detect the phosphorylation level of AKT / PI3K / mTOR pathway in human microvascular endothelial cells after LEDs illumination.

[0023] Figure 6 :LEDs 590nm yellow light inhibits the migration ability and secretion of VEGFA of human microvascular endothelial cells by inhibiting the AKT / PI3K / mTOR pathway.

[0024] Figure 7 : LEDs 590nm yellow light can effectively relieve facial erythema in patients with melasma. DETAILED DESCRIPTION

[0025] The present invention is further explained in conjunction with embodiments and corresponding drawings. The following embodiments are only for illustrative purposes and are not intended to limit the scope of the present invention.

[0026] Example 1: Experimental study on the effect of LED illumination on the activity and apoptosis of isolated human microvascular endothelial cells

[0027] In vitro culture of human microvascular endothelial cells: The cell line was purchased from Shanghai Guandao Bioengineering Co., Ltd. The surface of the T25 culture bottle containing the human microvascular endothelial cell line was disinfected and placed in a CO2 incubator for 2 hours; the original culture medium was discarded and 5 ml of complete culture medium (DMEM + 10% FBS + 1% double antibody) was added; when the human microvascular endothelial cells grew to 70%-80% confluence, the original culture medium was discarded and washed 3 times with PBS; 1 ml of trypsin-EDTA (0.25% ) Digest the cells. After about 30 seconds, the cells begin to become round and float. Observe the cell morphology under a microscope. After the cells begin to become round and float and detach from the bottom of the bottle, immediately add an equal amount of complete culture medium to terminate the digestion. Tap the bottle gently, use a Pasteur pipette to absorb the cell suspension, and centrifuge it in a low-speed centrifuge at 1000r / min for 5 minutes. Discard the waste liquid, add an appropriate amount of complete culture medium to resuspend the cells, inoculate them in a T25 culture bottle at a density of 2×105 / ml, and culture them at 37℃5% CO2. Subculture once every 2-3 days according to the growth status of the cells.

[0028] Detection of cell activity: human microvascular endothelial cells in the logarithmic growth phase within the 10th generation were inoculated in a 96-well plate at a density of 1×104 / well and cultured at 37°C for 24 hours; different doses of 590nm LEDs were used to irradiate the cells, and three replicate wells were set up for each dose; 10ul CCK-8 solution was added to each well of cells 12h, 24h and 48h after the irradiation; the 96-well plate was placed in a 37°C incubator for continued culture, and the absorbance value at 450nm was measured every hour with an enzyme marker within 0-4h after the addition of CCK-8 solution, and the cell viability was calculated, and the results of the three replicate wells were averaged; cells of different generations were selected for three repeated experiments.

[0029] Detection of cell apoptosis: human microvascular endothelial cells in the logarithmic growth phase within the 10th generation were inoculated in a 6-well plate at a density of 5×105 / well and cultured at 37°C for 24 hours; cells were irradiated with different doses of 590nm LEDs yellow light; after 24 hours, each group of cells was digested with 0.25% trypsin without EDTA, transferred to a 15ml centrifuge tube and centrifuged at 1000r / min for 5 minutes; the supernatant was discarded, the cells were resuspended with 4°C PBS, centrifuged at 400g for 5 minutes, and the cells were washed twice; 10×Binding Buffer was diluted to 1× with double distilled water, 300ul Binding Buffer was added to each tube to resuspend the cells and transferred to the flow cytometry loading tube; 5μL Annexin V FITC and 5μL PI were added to each tube, mixed and incubated at room temperature in the dark for 15 minutes; 200μL of cells were added to each tube 1×BindingBuffer, loaded on the machine within 30min; cells of different generations were selected for three repeated experiments, and the results were analyzed using FlowJo software.

[0030] Example 2: Scratch test to detect the migration ability of human microvascular endothelial cells in vitro after LED illumination

[0031] Scratch experiment: With the help of a ruler, use a marker to draw horizontal lines on the bottom of a 6-well plate, with 3 horizontal lines equally spaced in each well; take ex vivo human microvascular endothelial cells in the logarithmic growth phase within the 10th generation, inoculate them in a 6-well plate at a density of 5×105 / well, and culture them at 37℃5% CO2 until the cells grow to 100% confluence; use a 200ul pipette tip perpendicular to the bottom of the culture plate to draw three equidistant vertical lines perpendicular to the marked horizontal lines on the bottom of each well, and wash the detached cells with PBS; use different doses of 590nm LEDs yellow light to irradiate the cells; after irradiating the cells, switch to serum-free culture medium, place the 6-well plate in a 37℃ incubator for continued culture, use an inverted microscope to take bright field photos of the same position of each scratch at 0h, 24h, and 48h after scratching, use ImageJ software to calculate the scratch area and the scratch healing rate; select cells of different generations for three repeated experiments.

[0032] Example 3: Tube formation experiment to detect the tube formation ability of human microvascular endothelial cells in vitro after LED illumination

[0033] Tube formation experiment: human microvascular endothelial cells in the logarithmic growth phase within the 10th generation were inoculated in a 6-well plate at a density of 5×105 / well and cultured at 37°C for 24 hours; the cells were irradiated with different doses of 590nm LEDs yellow light; Matrigel was melted in a 4°C refrigerator overnight, and the 96-well plate and 200ul pipette tip were pre-cooled at 4°C overnight; the 96-well plate was placed on ice, 50ul Matrigel was added to each well, placed in a 37°C incubator for 1 hour, and then placed in a 4°C refrigerator for equilibration for 10 minutes; human microvascular endothelial cells 24 hours after irradiation were inoculated in a 96-well plate covered with matrix gel at a density of 5×104 / well; the cells were cultured in a 37°C incubator for 8 hours, bright field photos were taken using an inverted microscope, and the number of tubes was calculated using Image J software; cells of different generations were selected for three repeated experiments.

[0034] Example 4: RT-PCR and ELISA experiments to detect the synthesis and secretion of VEGFA and SCF by human microvascular endothelial cells in vitro after LED illumination

[0035] RT-PCR experiment: Wash the bottom cells of the 6-well plate to be extracted with PBS, add 500ul Trizol lysis buffer to each well of cells, mix repeatedly by pipetting, and let stand at room temperature for 5min; extract RNA; configure the reverse transcription system according to the instructions of PrimeScriptTM RTMasterMix reverse transcription kit: 2μl 5X PrimeScript RT Master Mix+500ng RNA sample, add DEPC water to make up to 10μl; place the configured sample in the PCR instrument, and set the reverse transcription program according to the instructions of the kit: 37℃, 15min, 85℃, 5s; 4℃, maintain; dilute the obtained cDNA sample 10 times; configure 10ul reaction system according to the instructions of TBGreen Premix Ex TaqTMⅡ kit; place the configured sample in the QuantStudio 6PCR instrument system for rt-PCR amplification, and set the reaction program according to the instructions of the kit: Stage 1: number of cycles: 1, 95℃, 30s; Stage 2: number of cycles: 40, 95℃, 5s, 60℃, 34s.

[0036] ELISA experiment: extract cell supernatant; transfer the cell supernatant in the 6-well plate after intervention to a labeled 1.5 ml EP tube, centrifuge at 300 g for 10 min, and store at -80 °C for later use; prepare a standard curve; dilute the sample with double distilled water to 1× concentrated wash solution, add 300 μl wash solution and soak for 30 seconds; add 100 ul of standard and the cell supernatant to be tested to each well of the 96-well plate, and add 50 μl to each well Dilute the detection antibody at 1:100 and seal the plate with a sealing film; incubate at room temperature for 2 hours; discard the liquid in the 96-well plate, add 300μl of washing solution to each well to wash the plate, oscillate for 30 seconds and discard the washing solution, pat dry on absorbent paper, and wash 6 times; dilute horseradish peroxidase-labeled streptavidin at 1:100; add 100μl of diluted horseradish peroxidase-labeled streptavidin to each well and seal the plate with a new sealing film; oscillate at 300r / min and incubate at room temperature for 45min; wash; add 100μl of chromogenic substrate TMB to each well and incubate at room temperature for 20min away from light; add 100μl of stop solution to each well and tap the plate frame to mix thoroughly; detect the OD value and calculate it.

[0037] Example 5: Western Blot method to detect the phosphorylation level of AKT / PI3K / mTOR pathway in human microvascular endothelial cells after LED illumination

[0038] Western Blot method: Use different doses of LEDs 590nm yellow light to illuminate the isolated human microvascular endothelial cells; wash the cells once with PBS 0.5h after illumination, mix an appropriate amount of strong RIPA lysis buffer and 1% PMSF evenly to prepare protein samples; load 4%-12% Bis-Tris 12-well precast gel into the fixed frame and put it into the electrophoresis tank; pour the electrophoresis solution into the electrophoresis tank, pull out the comb, fill it with electrophoresis solution, load the prepared protein samples and pre-stained protein markers in order, and fill the empty sample holes on both sides with waste samples; cover the corresponding positive and negative electrodes with lids, and use the electrophoresis instrument at 150V Protein electrophoresis was performed for 60 minutes; methanol was used to activate the PVDF membrane, and then it was placed in the PVDF membrane equilibration solution for 1 minute; a sponge pad was laid flat on the side of the transfer clip marked as the positive electrode, the PVDF membrane was first laid flat on the sponge pad, and the gel was laid flat on the membrane, and the bubbles were gently rolled with a roller, and finally the sponge pad was laid flat on the gel, the transfer clip was closed and loaded into the rapid transfer instrument; the membrane was transferred using a rapid wet transfer instrument with the parameters set to 2×4.5min; blocking; incubation with antibodies; and finally development: excess liquid was absorbed with filter paper, the PVDF membrane was laid flat on a 10cm culture dish, the developer was evenly dropped on the PVDF membrane until it was completely immersed, incubated in the dark for 3 minutes, and developed in a chemiluminescence image analysis system; the grayscale of the bands was analyzed using Image J software.

[0039] Example 6: LEDs 590nm yellow light inhibits the migration ability and secretion of VEGFA of isolated human microvascular endothelial cells by inhibiting the AKT / PI3K / mTOR pathway

[0040] IGF-1 pretreatment of cells: Take well-growing ex vivo human microvascular endothelial cells, inoculate them in a 6-well plate at a density of 5×105 / well, and culture them in a cell culture incubator at 37°C and 5% CO2 for 24 hours; discard the original culture medium, add 50ng / ml IGF-1 to the phenol red-free DMEM culture medium, add 1ml of culture medium containing IGF-1 to each well, and place them in an incubator for pretreatment for 2 hours; use different doses of 590nm LEDs yellow light to irradiate the cells for subsequent experiments.

[0041] Subsequent scratch assay and ELISA assay were the same as described above.

[0042] Example 7: Clinical trial of LEDs 590nm yellow light effectively alleviating facial erythema in patients with chloasma

[0043] Eleven patients with melasma who met the inclusion criteria and signed written informed consent were enrolled and treated with LED spectrum therapy device (manufacturer: Xuzhou Kono Medical Instrument Equipment Co., Ltd., model: KN-7000C, output wavelength: 590±10nm, power density: 10mW / cm 2 , effective irradiation area: 26cm 2 ±10%, medical device registration certificate number: Su Xie No. 20162261288) for home phototherapy, wavelength 590±10nm, continuous mode, irradiation intensity 10mW / cm 2 , irradiation distance: 2cm±1cm, treatment duration 5 minutes, once a day, for 16 consecutive weeks, total irradiation dose 21J / (cm 2 *weeks), the clinical trial results showed that the chloasma on both cheeks of the trial patients improved, and the erythema index decreased significantly, indicating that the method of the present invention is helpful to establish a platform for intervention treatment and long-term maintenance intervention treatment for relieving pigment hyperplastic skin diseases such as chloasma combined with telangiectasia.

Claims

1. A method for inhibiting angiogenesis by using visible light based on LED light modulation technology. It is characterized in that The method comprises using a wavelength of 590±10nm and a power density of 35mW / cm 2 And the energy density is 20J / cm 2 or 40J / cm 2 Continuous mode LEDs yellow light is used to irradiate isolated human microvascular endothelial cells in vitro. The method can regulate the following functions of isolated human microvascular endothelial cells: it does not affect cell activity and apoptosis, inhibits cell migration and tube formation, inhibits cell synthesis and secretion of VEGFA and SCF, and inhibits the phosphorylation level of the cell AKT / PI3K / mTOR pathway.

2. The method according to claim 1, It is characterized in that The method uses a cell model to perform a screening experiment, which includes the following steps: (1) Human microvascular endothelial cell culture: 2×10 5 / mL density was inoculated into T25 culture flasks and cultured at 37°C. The culture medium was changed regularly and the cells were passaged every 2-3 days according to their growth status. (2) Using LEDs with a wavelength of 590±10nm and continuous emission mode to illuminate isolated human microvascular endothelial cells, the power measured after passing through the culture plate cover was 35mW / cm 2 , select the irradiation time according to the formula W = P × t; (3) Screening of safe doses of LEDs: Cell morphology was observed using an optical microscope, and cell activity and apoptosis were determined using the CCK8 method and Annexin V-FITC / PI flow cytometry double staining method. The effects of 590nm LED yellow light irradiation on cell activity and apoptosis were detected. The energy range of 0-40J / cm2 that had no effect on the activity and apoptosis of isolated human microvascular endothelial cells was screened out. 2 ; (4) According to the screening results of step (3), the isolated human microvascular endothelial cells were irradiated with different safe doses of 590 nm LED yellow light, and the cell migration ability was detected by a scratch test, the cell tube formation ability was detected by a tube formation test, the expression of VEGFA and SCF at the gene and protein levels was detected by RT-PCR and ELISA, and the AKT / PI3K / mTOR pathway was detected by Western Blot.